| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2007 | WO2007002670A3 Method of lowering intraocular pressure |
| 04/05/2007 | WO2007002172A3 Hiv-1 protease inhibitors |
| 04/05/2007 | WO2007000392A3 Chloro-substituted guanidines |
| 04/05/2007 | WO2006138163A3 Anti-hypercholesterolemic compounds |
| 04/05/2007 | WO2006136859A3 Indoli zine derivatives and their use as crth2 antagonists |
| 04/05/2007 | WO2006135480A3 Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
| 04/05/2007 | WO2006134457A3 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives |
| 04/05/2007 | WO2006130522A3 Methods and compositions for managing psychotic disorders |
| 04/05/2007 | WO2006128674A3 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 04/05/2007 | WO2006128089A3 Compositions and methods for treating tissue |
| 04/05/2007 | WO2006128022A3 Solid compositions and methods for treating middle-of-the night insomnia |
| 04/05/2007 | WO2006127406A3 Gel compositions for control of ecto-parasites |
| 04/05/2007 | WO2006124874A3 Inhibitors of b-raf kinase |
| 04/05/2007 | WO2006124684A3 Combination therapy comprising a taxane and a thymidylate synthase inhibitor |
| 04/05/2007 | WO2006122652A3 Thiosuccinic acid derivatives and the use thereof |
| 04/05/2007 | WO2006119309A3 19,26,27-TRINOR-1α,25-DIHYDROXYVITAMIN D3 COMPOUNDS |
| 04/05/2007 | WO2006117600A3 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies |
| 04/05/2007 | WO2006116311A3 Opioid receptor agonist compounds and their use in treatment of pain |
| 04/05/2007 | WO2006113568A3 Controlled delivery dosage form of tramadol and gabapentin |
| 04/05/2007 | WO2006110491A3 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 04/05/2007 | WO2006109324A3 Processes for preparation of amorphous cefepime acid addition salts |
| 04/05/2007 | WO2006105440A3 Nicotinamide riboside and analogues thereof |
| 04/05/2007 | WO2006105304A3 Phenyl and pyridyl lta4h modulators |
| 04/05/2007 | WO2006101859A3 Piperidinyl substituted cyclohexane-1,4-diamines |
| 04/05/2007 | WO2006101858B1 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 04/05/2007 | WO2006099468A3 Process for the purification of duloxetine hydrochloride |
| 04/05/2007 | WO2006096759A3 Methods and compositions for treating cancer |
| 04/05/2007 | WO2006096626A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 04/05/2007 | WO2006095098A3 Use of a non-photosynthetic, non-fructifying filamentous bacteria extract as a $g(g)$g(d)t lymphocyte activation and/or protection agent |
| 04/05/2007 | WO2006094384B1 Use of interleukin 17e for the treatment of cancer |
| 04/05/2007 | WO2006092822A3 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chloro phenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpi pεrazine, synthesis process and uses thereof |
| 04/05/2007 | WO2006092711A3 Extended release tablets of metformin and glipizide |
| 04/05/2007 | WO2006091728A3 Microtubule stabilizing compounds and methods of their use |
| 04/05/2007 | WO2006089406A8 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 04/05/2007 | WO2006086447A3 Pyridazine derivatives and their use as therapeutic agents |
| 04/05/2007 | WO2006084793A3 Film-coated tablets containing ibuprofen lysinate |
| 04/05/2007 | WO2006084251A3 Aqueous gel formulations containing immune reponse modifiers |
| 04/05/2007 | WO2006084197A3 Nitroxides for use in treating or preventing neoplastic disease |
| 04/05/2007 | WO2006084030B1 Small-molecule hsp90 inhibitors |
| 04/05/2007 | WO2006083682A3 Polymorphic forms of a gabaa agonist |
| 04/05/2007 | WO2006081327A3 Small molecules that reduce fungal growth |
| 04/05/2007 | WO2006079119A3 Modulation of th2 lineage commitment by t-bet |
| 04/05/2007 | WO2006078554A3 Cgrp receptor antagonists |
| 04/05/2007 | WO2006073601A3 Methods and compositions for rna interference |
| 04/05/2007 | WO2006060246A3 Apparatus and system having dry control gene silencing compositions |
| 04/05/2007 | WO2006059121A3 Modulators of spindle checkpoint kinases and a taxol |
| 04/05/2007 | WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 04/05/2007 | WO2006058248A3 Methods for increasing the immune response in an animal |
| 04/05/2007 | WO2006056695A8 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 04/05/2007 | WO2006050498A3 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 04/05/2007 | WO2006041635A3 Arylthiobenzylpiperidine derivatives |
| 04/05/2007 | WO2006026820A9 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 04/05/2007 | WO2006017148A3 Optically enhanced chiral ionic liquids |
| 04/05/2007 | WO2006014886A3 Calcium phosphate cements and methods for using the same |
| 04/05/2007 | WO2005086694A3 Occlusive biomedical devices, punctum plugs, and methods of use thereof |
| 04/05/2007 | WO2005067969A3 Combinations of serotonin reuptake inhibitors and imidazoline-i2-agonists |
| 04/05/2007 | WO2005000229A3 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 04/05/2007 | US20070079392 Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
| 04/05/2007 | US20070078513 Controllable drug releasing gradient coatings for medical devices |
| 04/05/2007 | US20070078262 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
| 04/05/2007 | US20070078189 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 04/05/2007 | US20070078188 Compositions comprising and methods of using norfluoxetine |
| 04/05/2007 | US20070078187 Methods for treating viral infections using polyamine analogs |
| 04/05/2007 | US20070078186 Methods for treating transthyretin amyloid diseases |
| 04/05/2007 | US20070078184 Amino alcohol derivatives, medicinal composition containing the same, and use of these |
| 04/05/2007 | US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/05/2007 | US20070078182 Compounds and methods for delivery of prostacyclin analogs |
| 04/05/2007 | US20070078181 Use of a beta-3-agonist for the treatment of patients with spinal cord injury and suffering from renal and bladder complaints |
| 04/05/2007 | US20070078180 Methods and compositions for stabilizing an antioxidant |
| 04/05/2007 | US20070078179 Use of a fibrate and orlistat for the treatment of obesity |
| 04/05/2007 | US20070078178 ethyl 3-[2-(4-chlorophenyl)-2-oxoethoxy]benzo[b]thiophene-2-carboxylate; non-insulin dependent diabetes, obesity, hypotensive agent; athrosclerosis, retinopathy |
| 04/05/2007 | US20070078177 Methods and compositions for treating non age related hearing impairment in a subject |
| 04/05/2007 | US20070078176 Keratinocyte growth factor receptor-tyrosine specific inhibitors for the prevention of cancer metastatis |
| 04/05/2007 | US20070078175 Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof |
| 04/05/2007 | US20070078174 Tizanidine compositions and methods of treatment using the compositions |
| 04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/05/2007 | US20070078172 Mao-b inhibitors useful for treating obesity |
| 04/05/2007 | US20070078170 Process for the preparation of pioglitazone |
| 04/05/2007 | US20070078169 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 04/05/2007 | US20070078168 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 04/05/2007 | US20070078167 Use of bipyridine compound 'Caerulomycin A' derivatives and analogs thereof as immunosuppressive agents |
| 04/05/2007 | US20070078166 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 04/05/2007 | US20070078165 Melanin-concentrating hormone (MCH) receptor antagonists, such as (S)-2-{(3R,4R)-4-[6-Fluoro-2-(1-hydroxy-1-methyl-ethyl)-5-methyl-benzoimidazol-1-yl]-3 methoxy-piperidin-1-ylmethyl}-indan-5-carbonitrile, useful as dietetics, anxiolytic agents, antidepressants and anorexigenic agents |
| 04/05/2007 | US20070078164 Hypotensive agents; cardiovascular disorders; anxiolytic agents; cognition activators; diabetic neuropathy; congestive heart failure; cardiomyopathy; kidney disease; Alzheimer's disease; vision defects |
| 04/05/2007 | US20070078163 Substituted pyrrolidine and related compounds |
| 04/05/2007 | US20070078162 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| 04/05/2007 | US20070078161 Crystalline forms of (+)- and (-) erythro-mefloquine hydrochloride |
| 04/05/2007 | US20070078160 3-[3-(1-Ethyl-4,4,6-trimethyl-2-oxo- 1,2,3,4-tetrahydro-quinolin-7-yl)-4- (2,2,2-trifluoro-ethoxy)-phenyl]- acrylic acid;Retinoid X Receptor (RXR) agonists useful for treating the onset of cancer and metabolic disorders such as diabetes, dyslipidemia, and hypercholesterolemia |
| 04/05/2007 | US20070078159 Has excellent characteristics in terms of physical properties (particularly, dissolution rate) and pharmacokinetics (particularly, bioavailability), and is extremely useful as an angiogenesis inhibitor or c-Kit kinase inhibitor |
| 04/05/2007 | US20070078158 Purification of montelukast |
| 04/05/2007 | US20070078157 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO)enzyme activity and VAP-1 mediated adhesion useful for treatment of diseases |
| 04/05/2007 | US20070078156 Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain |
| 04/05/2007 | US20070078155 Naphthyridin derivatives |
| 04/05/2007 | US20070078154 Quinoline potassium channel inhibitors |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070078152 Piperidine derivatives |
| 04/05/2007 | US20070078151 Crystalline and amorphous pyrimidine compounds and processes for preparing pyrimidine compounds |
| 04/05/2007 | US20070078150 Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 04/05/2007 | US20070078148 Agents for preventing and/or treating higher brain dysfunctions |
| 04/05/2007 | US20070078147 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |